Therefore, the upregulation of mitochondria fusion and oxidative phosphorylation contributes to plasticizer‐associated early onset of breast cancer in a SLC6A14‐dependent manner, and targeting SLC6A14 is revealed as a potential therapeutic strategy for EOBC patients. This evidence concerns the gene SLC6A14 and breast cancer.